Helsinki University Hospital

News

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with Finlan

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.